Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea / vomiting), hearing loss (hardness of hearing), tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; mannitol; citric acid monohydrate; purified talc - meniere's syndrome as defined by the following core symptoms: - vertigo (with nausea/vomiting): - hearing loss (hardness of hearing): - tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: citric acid; microcrystalline cellulose; mannitol; colloidal anhydrous silica; purified talc - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - betahistine dihydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea / vomiting), hearing loss (hardness of hearing), tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; crospovidone; stearic acid; povidone; lactose monohydrate; microcrystalline cellulose - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting); hearing loss (hardness of hearing); tinnitus.

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - betahistine dihydrochloride - tablet - betahistine dihydrochloride 8 mg - other nervous system drugs

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - betahistine dihydrochloride - tablet - betahistine dihydrochloride 16 mg - other nervous system drugs

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - betahistine dihydrochloride - tablet - betahistine dihydrochloride 24 mg - other nervous system drugs

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

accord healthcare limited - betahistine (betahistine dihydrochloride) - tablets - 16mg